133 related articles for article (PubMed ID: 31286540)
1. Biochemical regulation and structural analysis of copper-transporting ATPase in a human hepatoma cell line for Wilson disease.
Agnihotry S; Dhusia K; Srivastav AK; Upadhyay J; Verma V; Shukla PK; Ramteke PW; Gautam B
J Cell Biochem; 2019 Nov; 120(11):18826-18844. PubMed ID: 31286540
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.
Chandhok G; Horvath J; Aggarwal A; Bhatt M; Zibert A; Schmidt HH
World J Gastroenterol; 2016 Apr; 22(16):4109-19. PubMed ID: 27122662
[TBL] [Abstract][Full Text] [Related]
3. Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis.
Polishchuk EV; Merolla A; Lichtmannegger J; Romano A; Indrieri A; Ilyechova EY; Concilli M; De Cegli R; Crispino R; Mariniello M; Petruzzelli R; Ranucci G; Iorio R; Pietrocola F; Einer C; Borchard S; Zibert A; Schmidt HH; Di Schiavi E; Puchkova LV; Franco B; Kroemer G; Zischka H; Polishchuk RS
Gastroenterology; 2019 Mar; 156(4):1173-1189.e5. PubMed ID: 30452922
[TBL] [Abstract][Full Text] [Related]
4. A systems biology approach reveals new endoplasmic reticulum-associated targets for the correction of the ATP7B mutant causing Wilson disease.
Concilli M; Iacobacci S; Chesi G; Carissimo A; Polishchuk R
Metallomics; 2016 Sep; 8(9):920-930. PubMed ID: 27714068
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of hepatic multi-drug resistance protein 1 (MDR1) after copper exposure.
Groba SR; Guttmann S; Niemietz C; Bernick F; Sauer V; Hachmöller O; Karst U; Zischka H; Zibert A; Schmidt HH
Metallomics; 2017 Sep; 9(9):1279-1287. PubMed ID: 28805879
[TBL] [Abstract][Full Text] [Related]
6. A new Caenorhabditis elegans model to study copper toxicity in Wilson disease.
Catalano F; O'Brien TJ; Mekhova AA; Sepe LV; Elia M; De Cegli R; Gallotta I; Santonicola P; Zampi G; Ilyechova EY; Romanov AA; Samuseva PD; Salzano J; Petruzzelli R; Polishchuk EV; Indrieri A; Kim BE; Brown AEX; Puchkova LV; Di Schiavi E; Polishchuk RS
Traffic; 2024 Jan; 25(1):e12920. PubMed ID: 37886910
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mutation spectrum and identification of novel mutations in ATP7B gene from a cohort of Wilson disease patients: Functional and therapeutic implications.
Kumari N; Kumar A; Thapa BR; Modi M; Pal A; Prasad R
Hum Mutat; 2018 Dec; 39(12):1926-1941. PubMed ID: 30120852
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells.
Parisi S; Polishchuk EV; Allocca S; Ciano M; Musto A; Gallo M; Perone L; Ranucci G; Iorio R; Polishchuk RS; Bonatti S
Sci Rep; 2018 Apr; 8(1):6247. PubMed ID: 29674751
[TBL] [Abstract][Full Text] [Related]
9. A glimpse into the regulation of the Wilson disease protein, ATP7B, sheds light on the complexity of mammalian apical trafficking pathways.
Gupta A; Das S; Ray K
Metallomics; 2018 Mar; 10(3):378-387. PubMed ID: 29473088
[TBL] [Abstract][Full Text] [Related]
10. A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease.
Greig JA; Nordin JML; Smith MK; Ashley SN; Draper C; Zhu Y; Bell P; Buza EL; Wilson JM
Hum Gene Ther Clin Dev; 2019 Mar; 30(1):29-39. PubMed ID: 30693797
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B.
Concilli M; Petruzzelli R; Parisi S; Catalano F; Sirci F; Napolitano F; Renda M; Galietta LJV; Di Bernardo D; Polishchuk RS
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32453-32463. PubMed ID: 33288711
[TBL] [Abstract][Full Text] [Related]
12. The six metal binding domains in human copper transporter, ATP7B: molecular biophysics and disease-causing mutations.
Ariöz C; Li Y; Wittung-Stafshede P
Biometals; 2017 Dec; 30(6):823-840. PubMed ID: 29063292
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent changes of cerebral copper metabolism in Atp7b
Xie F; Xi Y; Pascual JM; Muzik O; Peng F
Metab Brain Dis; 2017 Jun; 32(3):717-726. PubMed ID: 28130615
[TBL] [Abstract][Full Text] [Related]
14. Wilson disease and related copper disorders.
Lorincz MT
Handb Clin Neurol; 2018; 147():279-292. PubMed ID: 29325617
[TBL] [Abstract][Full Text] [Related]
15. Liver Expression of a MiniATP7B Gene Results in Long-Term Restoration of Copper Homeostasis in a Wilson Disease Model in Mice.
Murillo O; Moreno D; Gazquez C; Barberia M; Cenzano I; Navarro I; Uriarte I; Sebastian V; Arruebo M; Ferrer V; Bénichou B; Combal JP; Prieto J; Hernandez-Alcoceba R; Gonzalez Aseguinolaza G
Hepatology; 2019 Jul; 70(1):108-126. PubMed ID: 30706949
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.
van den Berghe PV; Stapelbroek JM; Krieger E; de Bie P; van de Graaf SF; de Groot RE; van Beurden E; Spijker E; Houwen RH; Berger R; Klomp LW
Hepatology; 2009 Dec; 50(6):1783-95. PubMed ID: 19937698
[TBL] [Abstract][Full Text] [Related]
17. Human copper transporter ATP7B (Wilson disease protein) forms stable dimers
Jayakanthan S; Braiterman LT; Hasan NM; Unger VM; Lutsenko S
J Biol Chem; 2017 Nov; 292(46):18760-18774. PubMed ID: 28842499
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?
Forbes JR; Cox DW
Am J Hum Genet; 1998 Dec; 63(6):1663-74. PubMed ID: 9837819
[TBL] [Abstract][Full Text] [Related]
19. Wilson Disease: Intersecting DNA Methylation and Histone Acetylation Regulation of Gene Expression in a Mouse Model of Hepatic Copper Accumulation.
Sarode GV; Neier K; Shibata NM; Shen Y; Goncharov DA; Goncharova EA; Mazi TA; Joshi N; Settles ML; LaSalle JM; Medici V
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1457-1477. PubMed ID: 34098115
[TBL] [Abstract][Full Text] [Related]
20. [Progress in molecular mechanism of hepatolenticular degeneration induced by ATP7B gene mutation].
Jia SY; Zhou DH; Ou XJ; Huang J
Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):188-192. PubMed ID: 32164076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
